J&J Patent Infringement Suit Aims To Slow Down Boston Scientific Express

Johnson & Johnson's decision to aggressively defend a 15-year-old stent patent against Boston Scientific represents a low-risk/high-reward strategy for J&J in the emerging drug-eluting stent market